ATNM Award Disclosure
Seth Sandesh · SEC Form 4 · Filed Sep 4, 2026
Award
Calculated transaction value
$0
Seth Sandesh Chief Executive Officer
ATNM
Transaction date
Sep 2, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 2 days later
ATNM daily price context
Close on/before transaction
$1
Sep 2, 2026
Close before public filing
$1.05
Sep 3, 2026
Return since public filing
+35.24%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 1,130,400 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-097741
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. ATNM | Award | Sep 2, 2026 | $0 |
| Actinium Pharmaceuticals, Inc. ATNM | Award | Sep 2, 2026 | $0 |
| Actinium Pharmaceuticals, Inc. ATNM Current | Award | Sep 2, 2026 | $0 |